HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic inhibition of the norepinephrine transporter in the brain participates in seizure sensitization to cocaine and local anesthetics.

Abstract
The involvement of chronic inhibition of monoamine transporters (MAT) in the brain with respect to sensitization to cocaine- and local anesthetic-induced seizures was studied in mice. Repeated administration of subconvulsive doses of meprylcaine as well as cocaine, both of which inhibit MAT, but not lidocaine, which does not inhibit MAT, increased seizure activity and produced sensitization to other local anesthetics. The effects of five daily treatments of monoamine transporter inhibitors on lidocaine-induced convulsions were examined 2 or 3 days after the last dose of the inhibitors. Daily treatments of GBR 12935, a specific inhibitor of dopamine uptake, significantly increased the incidence and the intensity of lidocaine-induced convulsions at 20 mg/kg and decreased the threshold of the convulsions. Daily treatments of desipramine and maprotiline, selective norepinephrine uptake inhibitors, markedly increased the incidence and intensity of lidocaine-induced convulsions, and decreased the threshold in a dose-dependent manner at between 5 and 20 mg/kg. Daily treatments of citalopram, a selective serotonin uptake inhibitor, at 10 and 20 mg/kg, produced no significant increase in the incidence or intensity of lidocaine-induced convulsions, but decreased the threshold of the convulsions. These results suggest that the chronic intermittent inhibition of monoamine uptake increases susceptibility to cocaine- and local anesthetic-induced seizures, and the norepinephrine transporter is an integral component of this sensitization.
AuthorsShigeaki Arai, Katsuya Morita, Shigeo Kitayama, Kei Kumagai, Michio Kumagai, Kenji Kihira, Toshihiro Dohi
JournalBrain research (Brain Res) Vol. 964 Issue 1 Pg. 83-90 (Feb 21 2003) ISSN: 0006-8993 [Print] Netherlands
PMID12573515 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic Uptake Inhibitors
  • Anesthetics, Local
  • Dopamine Uptake Inhibitors
  • Norepinephrine Plasma Membrane Transport Proteins
  • Piperazines
  • Serotonin Uptake Inhibitors
  • Slc6a2 protein, mouse
  • Symporters
  • Citalopram
  • Maprotiline
  • Lidocaine
  • 1-(2 (diphenylmethoxy)ethyl)-4-(3-phenylpropyl)piperazine
  • Cocaine
  • Desipramine
Topics
  • Adrenergic Uptake Inhibitors
  • Anesthetics, Local (adverse effects)
  • Animals
  • Brain (drug effects, metabolism, physiopathology)
  • Brain Chemistry (drug effects, physiology)
  • Citalopram (pharmacology)
  • Cocaine (adverse effects)
  • Desipramine (pharmacology)
  • Dopamine Uptake Inhibitors (pharmacology)
  • Dose-Response Relationship, Drug
  • Lidocaine (pharmacology)
  • Male
  • Maprotiline (pharmacology)
  • Mice
  • Mice, Inbred ICR
  • Norepinephrine Plasma Membrane Transport Proteins
  • Piperazines (pharmacology)
  • Seizures (chemically induced, metabolism, physiopathology)
  • Selective Serotonin Reuptake Inhibitors (pharmacology)
  • Symporters (drug effects, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: